The S&P 500 Index is at a two-month low. How real is the main concern, which is slowing global growth?
There is some basis for nervousness. German industrial production is down 4.0 percent month-over-month; August exports tumbled 5.8 percent month-over-month. Meanwhile, Italian third quarter GDP will likely be negative, and even Germany will be lucky if it ekes out a 1 percent gain.
Even International Monetary Fund chief Christine Lagarde is downbeat; the IMF this week said that the euro zone faces a one-in-three risk of falling back into a recession within the next six months.
China’s growth is expected to slow down; most commentaries I have seen expect Chinese GDP to be down to roughly 7.2 percent in the third quarter, from 7.5 percent in the second. It may drop even lower next year. There’s very little room to keep cutting rates, since they are worried about a real estate bubble.
That being said, I am not convinced we are headed for a significant correction. We have an ongoing recovery in the U.S. economy, the Federal Reserve reminded us on Wednesday that they are likely to remain dovish, and other central banks have certainly signaled they will continue with easy money policies.
However, overnight Microchip Technology, a manufacturer of specialty semiconductors, warned of lower revenues due to softer China sales (they get about 60 percent of revenues from Asia). The debate is whether this is company specific or not; some believe the company’s broad offerings make it a good early barometer.
Susquehanna, for example, said “MCHP’s pre-announcement last night leaves us with little doubt that an industry correction is upon us.” Still, we haven’t heard of a slowdown in chip sales to any extent prior to this.
Still, there are a number of unknown factors that are very difficult to model, the primary concern is Ebola. There has been quite a lot of healthy debate about whether the media is “hyping” the contagion scare. I’m very sensitive to these concerns—there’s no doubt the media can get obsessive about certain issues—but in the case of Ebola I think there is cause for serious concern.
Jack Rivkin and others have noted that the main issue is not death by virus. It’s the impact on psychology which which in turn affects activity. In extreme cases, it could result in significant declines in economic activity if a critical mass of cases occurs in dense urban areas. This could happen anywhere: including Bangkok, Mexico City, Managua, Lagos or New Delhi.
1) There’s a lot of pain in initial public offering (IPO) markets this morning. MOL Global (MOLG) had the worst IPO debut of any company in years. MOLG is the largest e-payment enabler for Southeast Asia, went public yesterday. They priced 13.5 million shares at $12.50, well below the 19.5 million shares at $12.50-$14.50. It opened at $10.35 and closed at $8.14, down roughly 50 percent.
The deal went from $263 million at the midpoint to $169.9 million!
Two IPOs priced last night and will trade today. On the NASDAQ, Dave & Buster’s Entertainment, which operates casual dining restaurants with large arcades, priced 5.9 million shares at $16, at the low end of the $16 to $18 range. On the NYSE, specialty drug distributor Diplomat Pharmacy priced 13.3 million shares at $13, below the $14 to $16 range.